GlassScriptPhysician profile
Samuel C Oliphant
NPI 1396750139
$1,801.70
in general payments reported to CMS, 2019-2025
9 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $75.30 · 2021: $58.11 · 2022: $488 · 2023: $562 · 2024: $185 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $621 · Travel and Lodging: $362 · Entertainment: $31.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $620.61 |
| Travel and Lodging | $361.58 |
| Entertainment | $31.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,224.53 | 2019-2025 | Total30, Precision 1, Dailies Total1 |
| Synergeyes, INC. | $230.34 | 2022 | |
| Coopervision INC. | $99.57 | 2021-2025 | Myday Contact Lens, Biofinity Contact Lens |
| Bausch & Lomb Americas INC. | $72.75 | 2024-2025 | Infuse, Biotrue One Day |
| Dompe US, INC. | $52.33 | 2022-2025 | Oxervate |
| Optos, INC. | $41.38 | 2019-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Lkc Technologies, INC. | $31.70 | 2025 | |
| Abb Con-Cise Optical Group LLC | $10.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Oliphant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.